PARTNERSHIP HEALTHPLAN OF CALIFORNIA. Review of 340B Models and Update on PHC s 340B Compliance Program

Size: px
Start display at page:

Download "PARTNERSHIP HEALTHPLAN OF CALIFORNIA. Review of 340B Models and Update on PHC s 340B Compliance Program"

Transcription

1 PARTNERSHIP HEALTHPLAN OF CALIFORNIA Review of 340B Models and Update on PHC s 340B Compliance Program 12/12/2014

2 Agenda Brief overview of 340B Program PHC 340B Program Update Comparison of 340B Models Future Growth of PHC 340B program

3 Brief overview of 340B Program For detailed white paper, contact:

4 Origin of the 340B Program The program extends mandated Medicaid drug discounts to other non-government entities. Purpose: To enable [participating] entities to stretch scarce Federal resources as far as possible, reaching more eligible patients and providing more comprehensive services. -PHS Act 1992

5 Models of Filling Prescriptions Using the 340B Program In-House Pharmacy (Including In-House Dispensaries) 340B Covered Entity owns drugs and is fiscally responsible for operation. Located on premises of the 340B Covered Entity For Medi-Cal: only 340B Medications would be used, regardless of PBM payment Contracted Pharmacy 340B Covered Entity owns drugs and pays dispensing fees to one or more contract pharmacies. 340B Covered Entity contracts with pharmacy to provide pharmacy services. For Medi-Cal: some prescriptions filled with 340B stock (if net income positive) others with non-340b inventory (if net income not positive).

6 340B Policy for Medicaid

7 340B Compliance: Medi-Cal Goal: Preventing duplicate discounts on medications. Three organizations must work together to make this work: HRSA holding Covered Entities accountable: Prohibits entities to bill in a way that results in the drug manufacturer paying a duplicate discount on a drug claim -HRSA FAQ, quoting 340B(a)(5) of PHS Act CMS holds State Medicaid agencies accountable: For ensuring that 340B Medications used by Medicaid beneficiaries are excluded from rebates normally given for the same medications; but they need to know a 340b Medication was used, for managed care. DHCS holds Medi-Cal Health Plans accountable: DHCS requires the Health Plan (such as PHC) to identify 340B drugs by tagging them with a specific code in a specific field in the monthly prescription file the Health Plan submits to DHCS.

8 Managed Care Plans May negotiate an arrangement different than AAC + Fill DHCS: The reimbursement rate is based on the contract rate of the individual plan. HRSA: [340B billing to Medicaid managed care plans] depends upon the billing agreement and is not determined by section 340B. Interpretation by Capture Rx: Excludes Medicaid from its 340B Program, nation-wide, unless there is agreement with managed care company that fulfills compliance requirements Other Health Plans and states

9 PHC 340B Policy PHC developed an agreement 340B Covered Entities will be invited to sign-up and participate. 340B Covered Entities that do not choose to sign-up, but choose to bill PHC for 340B Medications, will not be fulfilling their HRSA required 340B compliance responsibilities. PHC will not police/enforce this; it is up to HRSA to audit 340B Covered Entities for compliance and choose appropriate penalty.

10 PHC 340B Program Update

11 340B Program Status Update Pilot in July with six (6) sites of Shasta Community Health Center. On-boarding process in August 2014 delayed due to some issues between CaptureRx and Walmart. All issues have been resolved and on-boarding of all remaining sites has been successfully completed as of September 17, sites from six (6) entities are part of the Contract Pharmacy Program. 13 sites from one (1) entity are part of the In-House Pharmacy Program. The Phase II development in progress (includes Reporting and Invoicing Set-up). A 340B Compliance Program Policy approved by PHC Board On-boarding for January 2015 has begun for the Contract and In-House Pharmacy Programs.

12 340B Compliance Issues and the State Historical Claims PHC sent a letter to DHCS regarding the issue of historical 340B claims. Due to the logistical challenges, PHC recommended all prior 340B claims submitted before PHC s 340B Compliance Program be forgiven; that is not voided and rebilled. DHCS responded to PHC noting it could not ignore federal law and forgive duplicate discounts. Historical data incorrectly identified must be voided and re-submitted upon identification by the 340B Covered Entities. In light of the response from DHCS, PHC ed letters to all prospective 340B Covered Entities. The letter included information regarding the decision set forth by DHCS regarding historical claims.

13 340B Compliance Issues and the State (cont d) Present and Future To ensure compliance, HRSA requires 340B Covered Entities and Managed Care Plans like PHC to enter into agreements that prevent duplicate discounts. This agreement specifies how the 340B Covered Entity and the Plan will properly identify 340B medications so that the State does not receive discounts on those medications. This is part of the foundation of PHC s 340B Compliance Program. DHCS applauded the 340B Compliance Program and formally approved it as of 7/31/14. DHCS selected PHC s 340B Compliance Program as an example to model during a recent audit by the Office of the Inspector General (OIG) on rebates and 340B in Managed Care.

14 Comparison of 340B Models

15 Comparison of two models - Pros Contract with community pharmacies Operationally easier for providers and health center Greater revenue (detailed modeling later) In-House pharmacy only More control over pharmacy operation May use pharmacy staff for other purposes (higher marginal costs for meds) Easier for patients to pick up at visit/easier starts Compliance easier to monitor

16 Comparison of two models - Cons Contract with community pharmacies Small health centers: low volume makes program less viable for pharmacies Depends on cooperation of different chains with 340B Administrator Depends on willingness of 340B administrator to work with PHC 340BX Clearinghouse Compliance more complex In-House pharmacy only Need to hire and supervise pharmacy staff Regulation of having In- House pharmacy Need to get inspection and approval from PBM to bill for meds for PHC members Health center may not be as convenient for patients as neighborhood

17 Modeling 340B Revenue Variables to consider Part I Total number of PHC patients, capitated and special members Number of prescriptions per month (0.8 overall, average) Percentage of prescriptions written by PCP Percentage of prescriptions filled at 340B pharmacy Generic use rate (87% average) PHC Compliance fee: ($4.50 for Contracted; $0.01 In-House)

18 Modeling 340B Revenue Variables to consider Part II 340B administrator fee (Contracted model) Pharmacy fill fee (Contracted model) Fixed and marginal costs (In-House model) Monthly cost for Health Center to monitor 340B administrator (Contracted model) Average income (PBM payment 340B Acquisition Cost) for each model: Sample data analysis: $33 per script for In-House $200 per script for Contract

19 340B Income Model: Real time review

20 Estimating 340B Income Monthly Income Number of Patients IH Model Contracted Model Mixed model 1000 ($7,500) ($940) ($11,500) 2000 ($5,200) $3,100 ($8,000) 5000 $2,090 $15,300 $2, $14,000 $36,000 $19, $26,000 $56,000 $37, $38,000 $76,000 $55, $50,000 $97,000 $72, $63,000 $117,000 $90,000 $140, B Income by Health Center PHC population $120,000 $100,000 $80,000 $60,000 $40,000 $20,000 $0 ($20,000) IH Model Contracted Model Mixed model

21 Anticipated Growth of 340B Program at PHC

22 340B Entities in PHC Service Area B Covered Entities ( Entities ) within 14 county service area # of Entities Compliance/Contracting Status # of Actual Agreements 40 Entities that have signed an Agreement with PHC 6 Contract (27 sites) 1 In-House (13 sites) 127 Entities planning to sign an Agreement with PHC 27 Contract 12 In-House 42 Entities reporting they will not bill PHC in the future N/A 3 Entities who have not responded N/A Entities Planning to Sign an Agreement # of Entities Type of Pharmacy Arrangement (self-reported) 59 Contract 37 In-House 31 Both

23 Steps for Contracting with PHC s 340B Compliance Program The 340B Covered Entity responds to the initial letter from the PHC 340B Project Coordinator. The 340B Covered Entity Enters into agreement with PHC based on the 340B Compliance Program On-boarding Schedule. The 340B Covered Entity s 340B Administrator/Third Party Administrator (TPA) must be able to work with 340BX Clearinghouse (CaptureRx). On-boarding of new 340B Covered Entities occurs on a quarterly basis. The 340B Covered Entity provides proposed measures for the 340B QIP/PQP to PHC for approval by PHC s 340B Advisory Committee.

24 Questions?

25 Thank You

The 3 Keys to Success in Your 340B Program. Rob Nahoopii, PharmD, MS, BCPS CEO Turnkey Pharmacy Solutions A 340B Management Company

The 3 Keys to Success in Your 340B Program. Rob Nahoopii, PharmD, MS, BCPS CEO Turnkey Pharmacy Solutions A 340B Management Company The 3 Keys to Success in Your 340B Program Rob Nahoopii, PharmD, MS, BCPS CEO Turnkey Pharmacy Solutions A 340B Management Company Objectives Provide a description and overview of the 340B program Discuss

More information

Keep Your Savings: 340B Audits and Ensuring Compliance

Keep Your Savings: 340B Audits and Ensuring Compliance Keep Your Savings: 340B Audits and Ensuring Compliance Disclosure This presentation reflects experience with the topics at hand and does not constitute legal advice, and does not reflect interpretation

More information

The 340B Drug Pricing Program. Ariel Winter and Daniel Zabinski November 6, 2014

The 340B Drug Pricing Program. Ariel Winter and Daniel Zabinski November 6, 2014 The 340B Drug Pricing Program Ariel Winter and Daniel Zabinski November 6, 2014 Outline Background on 340B program Program has grown substantially 340B statute does not define key terms, allows many providers

More information

340B Drug Discount Program Identifying risks and internal audit focus areas

340B Drug Discount Program Identifying risks and internal audit focus areas 340B Drug Discount Program Identifying risks and internal audit focus areas Introduction The 340B Drug Discount Program is administered by the Health Resources and Services Administration (HRSA) Office

More information

Speakers. Recent Developments in 340B Drug Pricing Program Compliance and Enforcement. Elizabeth S. Elson, Esq. Anil Shankar, Esq.

Speakers. Recent Developments in 340B Drug Pricing Program Compliance and Enforcement. Elizabeth S. Elson, Esq. Anil Shankar, Esq. 1 Recent Developments in 340B Drug Pricing Program Compliance and Enforcement Elizabeth S. Elson, Esq. Anil Shankar, Esq. October 18, 2012 2 Speakers Elizabeth Elson Of Counsel Foley & Lardner LLP Los

More information

Pharmacy Benefit Managers

Pharmacy Benefit Managers Pharmacy Benefit Managers And the need for fair and reasonable standards over the practice of auditing pharmacies SB 175 Establishes Procedures & Guidelines for the Auditing of Pharmacy Records & Requires

More information

An Update on Acquisition Cost Based Reimbursement Models. Jerry Brehany, PharmD, PA-C, JD AVP Pharmacy Services

An Update on Acquisition Cost Based Reimbursement Models. Jerry Brehany, PharmD, PA-C, JD AVP Pharmacy Services An Update on Acquisition Cost Based Reimbursement Models Jerry Brehany, PharmD, PA-C, JD AVP Pharmacy Services Agenda Review current prescription drug pricing benchmarks Discuss new Acquisition Cost based

More information

C. Covered 340B drugs, as found in section 1927 (k)(2) of the Social Security Act, include the following outpatient drugs:

C. Covered 340B drugs, as found in section 1927 (k)(2) of the Social Security Act, include the following outpatient drugs: Title 23: Medicaid Part 200: General Provider Information Part 200 Chapter 4: Provider Enrollment Rule 4.10: 340B Providers A. The Division of Medicaid defines a 340B provider as a nonprofit healthcare

More information

XXXXXXXFUNDAMENTALS An Essential Guide for Health System Executive Management

XXXXXXXFUNDAMENTALS An Essential Guide for Health System Executive Management 340B XXXXXXXFUNDAMENTALS An Essential Guide for Health System Executive Management 800.473.3516 www.wellpartner.com Table of Contents 340B Fundamentals for Health System Executive Management...1 What

More information

Overview of the 340B Drug Pricing Program

Overview of the 340B Drug Pricing Program M a y 2 0 1 5 Report to the Congress Overview of the 340B Drug Pricing Program M a y 2 0 1 5 Report to the Congress Overview of the 340B Drug Pricing Program 425 I Street, NW Suite 701 Washington, DC 20001

More information

MEDICARE DRUG INTEGRITY CONTRACTORS IDENTIFICATION

MEDICARE DRUG INTEGRITY CONTRACTORS IDENTIFICATION Department of Health and Human Services OFFICE OF INSPECTOR GENERAL MEDICARE DRUG INTEGRITY CONTRACTORS IDENTIFICATION OF POTENTIAL PART D FRAUD AND ABUSE Daniel R. Levinson Inspector General October 2009

More information

California Primary Care Association 2012 New CFO Boot Camp

California Primary Care Association 2012 New CFO Boot Camp California Primary Care Association 2012 New CFO Boot Camp Medi-Cal FQHC PPS, Medicare FQHC, and Other Revenue/Reimbursement Strategies for Health Centers Presented by: Michael B. Schnake, CPA, CGFM Presentation

More information

Introduction to Medicare Like Reimbursements and 340B Prescription programs

Introduction to Medicare Like Reimbursements and 340B Prescription programs Introduction to Medicare Like Reimbursements and 340B Prescription programs Objectives Introduce Medicare Like Rate (MLR) Product & Processes Development of legal structure, documents and processes to

More information

340B Drug Pricing Program: Recent Developments and Compliance Update

340B Drug Pricing Program: Recent Developments and Compliance Update 340B Drug Pricing Program: Recent Developments and Compliance Update Elizabeth S. Elson, Esq. Anil Shankar, Esq. November 19, 2015 Attorney Advertising Prior results do not guarantee a similar outcome

More information

340B Drug Pricing Program

340B Drug Pricing Program 340B Drug Pricing Program Chad E. Gay Director of Contract Compliance Agenda Discuss the 340B drug pricing program How the program is defined Who is eligible Enrollment Dates to be aware of Source Documentation

More information

Iowa Medicaid Enterprise Average Actual Acquisition Cost Reimbursement Frequently Asked Questions

Iowa Medicaid Enterprise Average Actual Acquisition Cost Reimbursement Frequently Asked Questions Iowa Medicaid Enterprise Average Actual Acquisition Cost Reimbursement Frequently Asked Questions What are Average Actual Acquisition Cost (AAC) rates? Average Actual Acquisition Cost (AAC) rates are based

More information

Best Practices. How to Approach the State for Medicaid Dispute Resolution

Best Practices. How to Approach the State for Medicaid Dispute Resolution Best Practices How to Approach the State for Medicaid Dispute Resolution Panel Participants Manufacturer Representative: Michael Fraclose Analyst, Government Contracts, Cephalon Inc. State Representatives:

More information

340B DISCOUNT DRUG PROGRAM OVERVIEW

340B DISCOUNT DRUG PROGRAM OVERVIEW 340B DISCOUNT DRUG PROGRAM OVERVIEW March 2014 Investment banking services are provided by Harris Williams LLC, a registered broker-dealer and member of FINRA and SIPC, and Harris Williams & Co. Ltd, which

More information

340B Drug Pricing Program 340B Contract Pharmacy

340B Drug Pricing Program 340B Contract Pharmacy 340B Drug Pricing Program 340B Contract Pharmacy LTJG Enudio Mercado-Gonzalez, USPHS Program Management Officer U.S. Department of Health and Human Services Health Resources and Services Administration

More information

340B Integrity Audit: Is Your Hospital Ready for a HRSA Audit? February 4, 2013

340B Integrity Audit: Is Your Hospital Ready for a HRSA Audit? February 4, 2013 340B Integrity Audit: Is Your Hospital Ready for a HRSA Audit? February 4, 2013 1 Agenda 340B Program Overview Why HRSA Audits? What will HRSA Audits Cover? Verification of Eligibility: Covered Entity,

More information

ASHP Regulatory Alert

ASHP Regulatory Alert Proposed Guidance: 340B Drug Discount Program Introduction On Friday, August 28, 2015, the Health Resources and Services Administration (HRSA) published the long awaited proposed omnibus guidance for the

More information

TEXAS VENDOR DRUG PROGRAM PHARMACY PROVIDER PROCEDURE MANUAL

TEXAS VENDOR DRUG PROGRAM PHARMACY PROVIDER PROCEDURE MANUAL 1 OF 10 DOCUMENT HISTORY LOG STATUS REVISION EFFECTIVE DESCRIPTION Revision 1.1 Sep. 1, 2015 Baseline 1.0 Feb. 1, 2015 3.1 Eligible Entity 5 CAD Claim Submission o Instruction update and email address.

More information

CompPharma. Manage. Process. Inform. Ensure. The Role of a PBM in Workers Compensation

CompPharma. Manage. Process. Inform. Ensure. The Role of a PBM in Workers Compensation Manage Inform Process Ensure The Role of a PBM in Workers Compensation Understanding the role of workers compensation pharmacy benefit managers (WC-PBMs) can help state and local government agencies ensure

More information

340B Drug Discount Program Improving Compliance to Protect Savings and Be Audit Ready. Suzanne Herzog Founding Director Rx X Consulting

340B Drug Discount Program Improving Compliance to Protect Savings and Be Audit Ready. Suzanne Herzog Founding Director Rx X Consulting 340B Drug Discount Program Improving Compliance to Protect Savings and Be Audit Ready Suzanne Herzog Founding Director Rx X Consulting What is 340B? 340B Overview A drug discount program that allows covered

More information

HEALTH CENTER REIMBURSEMENT FOR PRESCRIPTION DRUGS: MEDICAID PPS AND SECTION 340B DRUG PRICING CONSIDERATIONS

HEALTH CENTER REIMBURSEMENT FOR PRESCRIPTION DRUGS: MEDICAID PPS AND SECTION 340B DRUG PRICING CONSIDERATIONS THE NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS, INC. ISSUE BRIEF # 20 Systems Development Series HEALTH CENTER REIMBURSEMENT FOR PRESCRIPTION DRUGS: MEDICAID PPS AND SECTION 340B DRUG PRICING CONSIDERATIONS

More information

COMPARING PHARMACY REIMBURSEMENT: MEDICARE PART D TO MEDICAID

COMPARING PHARMACY REIMBURSEMENT: MEDICARE PART D TO MEDICAID Department of Health and Human Services OFFICE OF INSPECTOR GENERAL COMPARING PHARMACY REIMBURSEMENT: MEDICARE PART D TO MEDICAID Daniel R. Levinson Inspector General February 2009 Office of Inspector

More information

The 340B Program: New Developments and New Opportunities for CAHs and Others. Todd Nova Hall Render

The 340B Program: New Developments and New Opportunities for CAHs and Others. Todd Nova Hall Render The 340B Program: New Developments and New Opportunities for CAHs and Others Todd Nova Hall Render Wisconsin Office of Rural Health Hospital Finance Workshop August 30, 2011 What We Will Cover 2 340B Program

More information

340B Compliance Self-Assessment: Self-Audit Process Page 1 A Sample Self-Audit Process for Community Health Centers

340B Compliance Self-Assessment: Self-Audit Process Page 1 A Sample Self-Audit Process for Community Health Centers 340B Compliance Self-Assessment: Self-Audit Process Page 1 Purpose: The purpose of this tool is to provide a sample internal audit process to assist participating community health center (CHC) leaders

More information

Affordable Care Act Reviews

Affordable Care Act Reviews Page 66 Appendix A Affordable Care Act Reviews The Office of Inspector General (OIG) is focused on promoting the economy, efficiency, and effectiveness of Affordable Care Act 1 programs across the Department

More information

NAMD WORKING PAPER SERIES. Medicaid and the 340B Program: Alignment and Modernization Opportunities

NAMD WORKING PAPER SERIES. Medicaid and the 340B Program: Alignment and Modernization Opportunities NAMD WORKING PAPER SERIES Medicaid and the 340B Program: Alignment and Modernization Opportunities May 2015 444 North Capitol Street, Suite 524 Washington, DC 20001 Phone: 202.403.8620 www.medicaiddirectors.org

More information

Will the ASP data submitted to CMS be releasable to the public?

Will the ASP data submitted to CMS be releasable to the public? FAQ Results Please be advised that these FAQs were generated from a database that is updated frequently. For the most up-to-date information, please visit http://questions.cms.hhs.gov. Date: 2/24/2010

More information

340B Drug Discount Program 2013 March 15, 2013 1 Agenda 340B Program Overview Covered Entities Covered Drugs Covered Patients Why HRSA Audits How to Prepare for HRSA Audit Questions/Answers 2 340 DRUG

More information

OIG Responses to Additional Questions from Chairman Pitts Regarding the 340B Program May 4, 2015

OIG Responses to Additional Questions from Chairman Pitts Regarding the 340B Program May 4, 2015 OIG Responses to Additional Questions from Chairman Pitts Regarding the 340B Program May 4, 2015 1. HRSA had been preparing a regulation to address the definition of a patient and hospital eligibility,

More information

Printed copies are for reference only. Please refer to the electronic copy of this policy for the latest version.

Printed copies are for reference only. Please refer to the electronic copy of this policy for the latest version. 340B Pharmacy Audit Policy Version: 1.4 Date Created: 01/05/2015 Date Approved: 02/18/2015 Printed copies are for reference only. Please refer to the electronic copy of this policy for the latest version.

More information

340B Drug Pricing Program. A Survey of the Program s Past, Present, and Future

340B Drug Pricing Program. A Survey of the Program s Past, Present, and Future 340B Drug Pricing Program A Survey of the Program s Past, Present, and Future Presented by: Daniel Soldato Wyatt, Tarrant & Combs LLP dsoldato@wyattfirm.com (859) 288-7631 Disclaimer The views expressed

More information

ATTACHMENT A - STATEMENT OF WORK REQUEST FOR PROPOSALS FOR INDEPENDENT BENEFIT CONSULTING, ACTUARIAL AND AUDITING SERVICES DMS-13/14-018

ATTACHMENT A - STATEMENT OF WORK REQUEST FOR PROPOSALS FOR INDEPENDENT BENEFIT CONSULTING, ACTUARIAL AND AUDITING SERVICES DMS-13/14-018 4050 Esplanade Way Tallahassee, Florida 32399-0950 Tel: 850.488.2786 Fax: 850. 922.6149 Rick Scott, Governor Craig J. Nichols, Agency Secretary ATTACHMENT A - STATEMENT OF WORK REQUEST FOR PROPOSALS FOR

More information

STATES COLLECTION OF REBATES FOR DRUGS PAID THROUGH MEDICAID MANAGED CARE ORGANIZATIONS

STATES COLLECTION OF REBATES FOR DRUGS PAID THROUGH MEDICAID MANAGED CARE ORGANIZATIONS Department of Health and Human Services OFFICE OF INSPECTOR GENERAL STATES COLLECTION OF REBATES FOR DRUGS PAID THROUGH MEDICAID MANAGED CARE ORGANIZATIONS Daniel R. Levinson Inspector General September

More information

Ensuring Integrity in use of 340B pricing: Responsibility, Compliance, Accountability

Ensuring Integrity in use of 340B pricing: Responsibility, Compliance, Accountability Ensuring Integrity in use of 340B pricing: Responsibility, Compliance, Accountability Fern Paul-Aviles, PharmD, MS, BCPS Director, 340B and Ambulatory Regulatory Program Compliance Carolinas Healthcare

More information

340B: ARE WE MONITORING COMPLIANCE EFFECTIVELY AND EFFICIENTLY

340B: ARE WE MONITORING COMPLIANCE EFFECTIVELY AND EFFICIENTLY CPAs & ADVISORS experience clarity // 340B: ARE WE MONITORING COMPLIANCE EFFECTIVELY AND EFFICIENTLY September 17, 2014 Michael Earls, CPA, Senior Manager September 17, 2014 OVERVIEW OF TODAY S PRESENTATION

More information

7/16/2010. 14 th Annual 340B Coalition Conference July 19, 2010 Washington, DC. Safety Net Hospitals for Pharmaceutical Access

7/16/2010. 14 th Annual 340B Coalition Conference July 19, 2010 Washington, DC. Safety Net Hospitals for Pharmaceutical Access Safety Net Hospitals for Pharmaceutical Access The Story From Washington, D.C. Ted Slafsky Executive Director, SNHPA Editor in Chief, Drug Discount Monitor (202)552-58605860 ted.slafsky@snhpa.org 14 th

More information

Closing the Coverage Gap

Closing the Coverage Gap MEDICARE PRESCRIPTION DRUG COVERAGE JANUARY 2012 Information Pharmacists Can Use on: Closing the Coverage Gap The Affordable Care Act includes provisions to close the Medicare Part D prescription drug

More information

MEDICARE PART B DRUGS. Action Needed to Reduce Financial Incentives to Prescribe 340B Drugs at Participating Hospitals

MEDICARE PART B DRUGS. Action Needed to Reduce Financial Incentives to Prescribe 340B Drugs at Participating Hospitals United States Government Accountability Office Report to Congressional Requesters June 2015 MEDICARE PART B DRUGS Action Needed to Reduce Financial Incentives to Prescribe 340B Drugs at Participating Hospitals

More information

-1058- BEFORE THE DEPARTMENT OF PUBLIC HEALTH AND HUMAN SERVICES OF THE STATE OF MONTANA ) ) ) ) )

-1058- BEFORE THE DEPARTMENT OF PUBLIC HEALTH AND HUMAN SERVICES OF THE STATE OF MONTANA ) ) ) ) ) -1058- BEFORE THE DEPARTMENT OF PUBLIC HEALTH AND HUMAN SERVICES OF THE STATE OF MONTANA In the matter of the amendment of ARM 37.85.104 and 37.85.105 pertaining to the revision of fee schedules for Medicaid

More information

Federal 340B Drug Pricing Program

Federal 340B Drug Pricing Program 2015 CliftonLarsonAllen LLP Federal 340B Drug Pricing Program March 6, 2015 Continuous learning in action Learning Objectives Explain the intent of the Federal 340B Drug Pricing Program List the eligibility

More information

The Pharmacy 340B Program- Compliance & Internal Audit Strategies. for Covered Entities. Matthew D. Vogelien Huron Healthcare

The Pharmacy 340B Program- Compliance & Internal Audit Strategies. for Covered Entities. Matthew D. Vogelien Huron Healthcare The Pharmacy 340B Program- Compliance & Internal Audit Strategies Matthew D. Vogelien Huron Healthcare for Covered Entities 340B Drug Discount Program (340B Program) Discussion Outline Topics for Discussion:

More information

Drug Price Types and Options for a Future Standard

Drug Price Types and Options for a Future Standard whitepaper Elsevier / Gold Standard: Drug Price Types and Options for a Future Standard Standardized price information is a vital part of the drug purchasing and reimbursement system. This white paper

More information

August 7, 2014. Dear Mr. Helgerson:

August 7, 2014. Dear Mr. Helgerson: August 7, 2014 Chain Pharmacy Association of New York State New York Chapter, American Society of Consultant Pharmacists New York State Council of Health System Pharmacists Pharmacists Society of the State

More information

RE: File Code CMS 2345 P: Medicaid Program; Covered Outpatient Drugs

RE: File Code CMS 2345 P: Medicaid Program; Covered Outpatient Drugs April 2, 2012 Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS 2345 P Mail Stop C4-26-05 7500 Security Boulevard Baltimore, MD 21244 1850 RE: File Code CMS

More information

Medicare Compliance, Fraud, Waste and Abuse Training for Medicare Part D- Contracted Pharmacies

Medicare Compliance, Fraud, Waste and Abuse Training for Medicare Part D- Contracted Pharmacies Medicare Compliance, Fraud, Waste and Abuse Training for Medicare Part D- Contracted Pharmacies 2008 Medco Health Solutions, Inc. All rights reserved. Training Introduction In this training, you ll learn

More information

Impact of Health Reform on Prescription Drugs

Impact of Health Reform on Prescription Drugs Impact of Health Reform on Prescription Drugs 1 Indirect Effects Increased Rx Volume = More Prescriptions! Page 2 Retiree Drug Subsidy (RDS) Before HCR Tax-Free Subsidy RDS as taxdeductible income After

More information

Update on Medicare Part D: 2009 and Beyond

Update on Medicare Part D: 2009 and Beyond Update on Medicare Part D: 2009 and Beyond 2009 NACDS Pharmacy & Technology Conference Christine C. Rinn Donald L. Bell, II Outline of Presentation» Introduction/Background on Part D» Trends in Part D»

More information

Structuring 340B Contract Pharmacy Arrangements: Meeting Legal and Regulatory Requirements

Structuring 340B Contract Pharmacy Arrangements: Meeting Legal and Regulatory Requirements Presenting a live 90-minute webinar with interactive Q&A Structuring 340B Contract Pharmacy Arrangements: Meeting Legal and Regulatory Requirements THURSDAY, JUNE 4, 2015 1pm Eastern 12pm Central 11am

More information

PST-5 Issued: June 1984 Revised: August 2015 GENERAL INFORMATION

PST-5 Issued: June 1984 Revised: August 2015 GENERAL INFORMATION Information Bulletin PST-5 Issued: June 1984 Revised: August 2015 Was this bulletin useful? THE PROVINCIAL SALES TAX ACT GENERAL INFORMATION Click here to complete our short READER SURVEY This bulletin

More information

4 Tips and 3 Pitfalls to Avoid when Sourcing Professional Services

4 Tips and 3 Pitfalls to Avoid when Sourcing Professional Services 4 Tips and 3 Pitfalls to Avoid when Sourcing Professional Services a Little Planning can Save Companies Millions S a f e S o u r c i n g, I n c. 2 8 1 5 0 N. A l m a S c h o o l P k w y S u i t e 1 0 3

More information

Affordable Care Act Reviews

Affordable Care Act Reviews Appendix A Affordable Care Act Reviews New Programs and Initiatives... 107 Pre-Existing Condition Insurance Plans, 1101... 107 Controls Over Pre-Existing Condition Insurance Plans and Collaborative Administration...

More information

Mega Guidance Is Here!

Mega Guidance Is Here! Mega Guidance Is Here! David Pointer has no actual or potential conflict of interest in relation to this presentation. 1 Introduction Where are we today? Brief Overview of HRSA Audit Findings Where are

More information

Mega Guidance Is Here!

Mega Guidance Is Here! Mega Guidance Is Here! David Pointer has no actual or potential conflict of interest in relation to this presentation. Introduction Where are we today? Brief Overview of HRSA Audit Findings Where are we

More information

Predictive Acquisition

Predictive Acquisition Predictive Acquisition Cost q Introduction to PAC Aprili 2013 Agenda Five key criteria for new price type Five key criteria for new price type What is PAC? Key milestones since launch Use cases across

More information

340B Drug Pricing Program January 15, 2015

340B Drug Pricing Program January 15, 2015 340B Drug Pricing Program January 15, 2015 340B Basics - Gary Merchant. MBA, BSPharm 340B Audit - Robert Theriault, MBA, BSPharm Declarations Neither Gary Merchant nor Robert Theriault have no actual or

More information

Medicare Part D Hospice Care Hospice Information for Medicare Part D Plans

Medicare Part D Hospice Care Hospice Information for Medicare Part D Plans P. O. Box 31397 Tampa, FL 33631 Medicare Part D Hospice Care Hospice Information for Medicare Part D Plans Table of Contents Introduction...2 Background...2 Purpose...2 1) To document that a drug is unrelated

More information

Page 2 Ms. Janna Zumbrun. HHS Action Official:

Page 2 Ms. Janna Zumbrun. HHS Action Official: Page 2 Ms. Janna Zumbrun HHS Action Official: Team Leader, Compliance Team, OFAM/DFI Rm 11A-55 Parklawn Building 5600 Fishers Lane Rockville, Maryland 20857 Department of Health and Human Services OFFICE

More information

Medical Care Advisory Committee. Andy Vasquez, Deputy Director, Medicaid/CHIP Vendor Drug Program Health and Human Services Commission

Medical Care Advisory Committee. Andy Vasquez, Deputy Director, Medicaid/CHIP Vendor Drug Program Health and Human Services Commission TO: Medical Care Advisory Committee DATE: November 8, 2013 FROM: Andy Vasquez, Deputy Director, Medicaid/CHIP Vendor Drug Program Health and Human Services Commission Agenda Item No.: 7 SUBJECT: Fee-for-Service

More information

UPDATED. Special Advisory Bulletin on the Effect of Exclusion from Participation in Federal Health Care Programs

UPDATED. Special Advisory Bulletin on the Effect of Exclusion from Participation in Federal Health Care Programs UPDATED Special Advisory Bulletin on the Effect of Exclusion from Participation in Federal Health Care Programs Issued May 8, 2013 Updated Special Advisory Bulletin on the Effect of Exclusion from Participation

More information

Affordable Care Act Reviews

Affordable Care Act Reviews Appendix A: Affordable Care Act Reviews Appendix A: Affordable Care Act Reviews New Programs and Initiatives Created by the Affordable Care Act... 1 Pre-Existing Condition Insurance Plans, 1101...2 Controls

More information

MEDICARE PART D E-PRESCRIBING STANDARDS: EARLY ASSESSMENT SHOWS PARTIAL CONNECTIVITY

MEDICARE PART D E-PRESCRIBING STANDARDS: EARLY ASSESSMENT SHOWS PARTIAL CONNECTIVITY Department of Health and Human Services OFFICE OF INSPECTOR GENERAL MEDICARE PART D E-PRESCRIBING STANDARDS: EARLY ASSESSMENT SHOWS PARTIAL CONNECTIVITY Daniel R. Levinson Inspector General October 2009

More information

HRSA Pharmacy Services Support Center: The 340B Access Resource

HRSA Pharmacy Services Support Center: The 340B Access Resource HRSA Pharmacy Services Support Center: The 340B Access Resource Lisa Scholz PharmD, MBA Vice President, APhA HRSA Pharmacy Services Support Center Office of Population Affairs Webinar 9/16 INTEGRITY ACCESS

More information

Pharmacy Benefit Managers: What we do

Pharmacy Benefit Managers: What we do Pharmacy Benefit Managers: What we do Steve Boekenoogen, Pharm.D. Poulsbo, WA & San Diego CA Manager, Clinical Services & Integration MedImpact Healthcare Systems, Inc Dan Danielson, M.S., RPh. Lynnwood,

More information

July 27, 2015. Dear Acting Administrator Slavitt:

July 27, 2015. Dear Acting Administrator Slavitt: Acting Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-2390-P P.O. Box 8106 Baltimore, MD 21244-8016 Re: Proposed Rule for Medicaid and Children

More information

SMAC represents the ceiling price that the program is going to reimburse for generics and is determined by:

SMAC represents the ceiling price that the program is going to reimburse for generics and is determined by: Maryland Generic PDL Analysis October 2012 Maryland Generic PDL Analysis Introduction Upon request by the Maryland Department of Health and Mental Hygiene, Magellan Medicaid Administration has completed

More information

340B Drug Discount Program Overview and Emerging Issues

340B Drug Discount Program Overview and Emerging Issues 340B Drug Discount Program Overview and Emerging Issues I. APPLICABLE STATUTE AND OTHER LEGAL AUTHORITIES Section 340B of the Public Health Service Act (42 U.S.C. 256b) requires pharmaceutical manufacturers,

More information

GAO PRESCRIPTION DRUGS. The Number, Role, and Ownership of Pharmacy Services Administrative Organizations

GAO PRESCRIPTION DRUGS. The Number, Role, and Ownership of Pharmacy Services Administrative Organizations GAO United States Government Accountability Office Report to the Ranking Member, Committee on Energy and Commerce, House of Representatives January 2013 PRESCRIPTION DRUGS The Number, Role, and Ownership

More information

Fraud Waste and Abuse Training First Tier, Downstream and Related Entities. ONECare by Care1st Health Plan Arizona, Inc. (HMO) Revised: 10/2009

Fraud Waste and Abuse Training First Tier, Downstream and Related Entities. ONECare by Care1st Health Plan Arizona, Inc. (HMO) Revised: 10/2009 Fraud Waste and Abuse Training First Tier, Downstream and Related Entities ONECare by Care1st Health Plan Arizona, Inc. (HMO) Revised: 10/2009 Overview Purpose Care1st/ ONECare Compliance Program Definitions

More information

Workers Compensation Compound Drug Costs. Management Advisory. Report Number HR-MA-16-003. March 14, 2016

Workers Compensation Compound Drug Costs. Management Advisory. Report Number HR-MA-16-003. March 14, 2016 Management Advisory Report Number HR-MA-16-003 March 14, 2016 Workers Compensation Compound Drug Costs In CBY 2015, the total number of Postal Service employees with compound drug prescriptions increased

More information

(RIN) 0906-AB08; 340-B

(RIN) 0906-AB08; 340-B October, 2015 Ms. Krista Pedley Director, Office of Pharmacy Affairs (OPA) Health Resources and Services Administration (HRSA) 5600 Fishers Lane, Mail Stop 08W05A Rockville, Maryland 20857 Re: Regulatory

More information

OREGON DID NOT BILL MANUFACTURERS FOR REBATES FOR PHYSICIAN-ADMINISTERED DRUGS DISPENSED TO ENROLLEES OF MEDICAID MANAGED-CARE ORGANIZATIONS

OREGON DID NOT BILL MANUFACTURERS FOR REBATES FOR PHYSICIAN-ADMINISTERED DRUGS DISPENSED TO ENROLLEES OF MEDICAID MANAGED-CARE ORGANIZATIONS Department of Health and Human Services OFFICE OF INSPECTOR GENERAL OREGON DID NOT BILL MANUFACTURERS FOR REBATES FOR PHYSICIAN-ADMINISTERED DRUGS DISPENSED TO ENROLLEES OF MEDICAID MANAGED-CARE ORGANIZATIONS

More information

GAO DRUG PRICING. Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs Improvement

GAO DRUG PRICING. Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs Improvement GAO United States Government Accountability Office Report to Congressional Committees September 2011 DRUG PRICING Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs

More information

340B Program New Developments and Increasing Scrutiny

340B Program New Developments and Increasing Scrutiny 340B Program New Developments and Increasing Scrutiny Todd Nova Hall Render tnova@hallrender.com Wisconsin Office of Rural Health Hospital Finance Workshop August 24, 2012 What We Will Cover 2 340B Program

More information

MEDICAID DRUG PRICE COMPARISON: AVERAGE SALES PRICE TO AVERAGE WHOLESALE PRICE

MEDICAID DRUG PRICE COMPARISON: AVERAGE SALES PRICE TO AVERAGE WHOLESALE PRICE Department of Health and Human Services OFFICE OF INSPECTOR GENERAL MEDICAID DRUG PRICE COMPARISON: AVERAGE SALES PRICE TO AVERAGE WHOLESALE PRICE Daniel R. Levinson Inspector General June 2005 OEI-03-05-00200

More information

TRADE AGREEMENTS ACT LIMITATIONS ON PROCUREMENT OF PHARMACEUTICALS AND POTENTIAL VA SOLUTIONS

TRADE AGREEMENTS ACT LIMITATIONS ON PROCUREMENT OF PHARMACEUTICALS AND POTENTIAL VA SOLUTIONS TRADE AGREEMENTS ACT LIMITATIONS ON PROCUREMENT OF PHARMACEUTICALS AND POTENTIAL VA SOLUTIONS Donna Lee Yesner Morgan, Lewis & Bockius, LLP dyesner@morganlewis.com (202)739-5887 The Trade Agreements Act,

More information

Medicare Compliance and Fraud, Waste, and Abuse Training

Medicare Compliance and Fraud, Waste, and Abuse Training Medicare Compliance and Fraud, Waste, and Abuse Training Objectives Recognize laws and concepts affecting compliance and fraud, waste, and abuse (FWA) Increase awareness of FWA Use identification techniques

More information

340B Compliance: I sure wish I d known that!

340B Compliance: I sure wish I d known that! 340B Compliance: I sure wish I d known that! Aaron K. Lott Pharm. D. Executive Director of Pharmacy Services June 2015 Disclosures The presenter has no significant financial or commercial interests to

More information

STATEMENT OF DIANA ESPINOSA DEPUTY ADMINISTRATOR, HEALTH RESOURCES AND SERVICES ADMINISTRATION BEFORE THE

STATEMENT OF DIANA ESPINOSA DEPUTY ADMINISTRATOR, HEALTH RESOURCES AND SERVICES ADMINISTRATION BEFORE THE STATEMENT OF DIANA ESPINOSA DEPUTY ADMINISTRATOR, HEALTH RESOURCES AND SERVICES ADMINISTRATION BEFORE THE U.S. HOUSE ENERGY AND COMMERCE COMMITTEE SUBCOMMITEE ON HEALTH WASHINGTON, D.C. MARCH 5, 2015 Good

More information

4/3/2015 WHAT IS 340B? DISCLOSURE. No conflicts of interest to disclose

4/3/2015 WHAT IS 340B? DISCLOSURE. No conflicts of interest to disclose WHAT IS 340B? S C O T T M I L N E R P H AR M D, M B A DISCLOSURE No conflicts of interest to disclose 1 OBJECTIVES At the end of this presentation we should be able to: Describe the origin of the 340b

More information

October 26, 2015. Submitted electronically via http://www.regulations.gov. Re: RIN 0906-AB08; 340B Drug Pricing Program Omnibus Guidance

October 26, 2015. Submitted electronically via http://www.regulations.gov. Re: RIN 0906-AB08; 340B Drug Pricing Program Omnibus Guidance 20555 Victor Parkway Livonia, MI 48152 tel 734-343-1000 trinity-health.org October 26, 2015 Captain Krista Pedley, PharmD, MS Director Office of Pharmacy Affairs Health Resources and Services Administration

More information

CPAs and ADVISORS. experience access // 340B QUALIFICATIONS, BENEFITS AND CURRENT FOCUS

CPAs and ADVISORS. experience access // 340B QUALIFICATIONS, BENEFITS AND CURRENT FOCUS CPAs and ADVISORS experience access // 340B QUALIFICATIONS, BENEFITS AND CURRENT FOCUS BRIAN M. BELL BRAD K. BROTHERTON DIRECTOR PARTNER MATERIALS COVERED TODAY 340B Program Evolution, Purpose & Benefits

More information

Crowe Healthcare Webinar Series

Crowe Healthcare Webinar Series New Payment Models Crowe Healthcare Webinar Series Audit Tax Advisory Risk Performance 2014 Crowe Horwath LLP Agenda Bundled Care for Payment Improvements Payment Models Accountable Care Organizations

More information

ARChoices. HPE Fiscal Agent for the Arkansas Division of Medical Services. September 2016

ARChoices. HPE Fiscal Agent for the Arkansas Division of Medical Services. September 2016 ARChoices HPE Fiscal Agent for the Arkansas Division of Medical Services September 2016 Topics for Today Provider Training Provider Manuals Submitting Claims Claim Adjustments and Voids Current CPT Codes

More information

Provider Adjustment, Time limit & Medicare Override Job Aid

Provider Adjustment, Time limit & Medicare Override Job Aid Provider Adjustment, Time limit & Medicare Override Job Aid Contents Overview... 1 Medicaid Resolution Inquiry Form... 1 Medicare Overrides... 3 Time Limit Overrides... 3 Adjusting a Claim through the

More information

O n Aug. 28, the Department of Health and Human

O n Aug. 28, the Department of Health and Human BNA s Health Law Reporter Reproduced with permission from BNA s Health Law Reporter, 24 HLR 1202, 9/17/15. Copyright 2015 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com HRSA

More information

Statement of the Biotechnology Industry Organization Before the Advisory Panel on Ambulatory Payment Classification Groups August 23-24, 2010

Statement of the Biotechnology Industry Organization Before the Advisory Panel on Ambulatory Payment Classification Groups August 23-24, 2010 Statement of the Biotechnology Industry Organization Before the Advisory Panel on Ambulatory Payment Classification Groups August 23-24, 2010 Laurel Todd Director, Reimbursement and Health Policy Biotechnology

More information

SECTION 12 - REIMBURSEMENT METHODOLOGY

SECTION 12 - REIMBURSEMENT METHODOLOGY SECTION 12 - REIMBURSEMENT METHODOLOGY 12.1 THE BASIS FOR ESTABLISHING A RATE OF PAYMENT...2 12.2 DETERMINING A FEE...2 12.2.A LONG-TERM CARE DISPENSING FEE REQUIREMENTS...3 12.3 MEDICARE/MEDICAID REIMBURSEMENT

More information

Trends in Weighted Average Sales Prices for Prescription Drugs in Medicare Part B, 2006-2014

Trends in Weighted Average Sales Prices for Prescription Drugs in Medicare Part B, 2006-2014 Trends in Weighted Average Sales Prices for Prescription Drugs in Medicare Part B, 2006-2014 September 2015 1 Trends in Estimated Average Sales Price for Prescription Drugs in Medicare Part B, 2006-2014

More information

ASO. BlueCross BlueShield of Oregon HOW AN ADMINISTRATIVE SERVICES ONLY (ASO) PLAN CAN WORK FOR YOU AN INTRODUCTION FOR GROUPS OF 51-99 MT HOOD

ASO. BlueCross BlueShield of Oregon HOW AN ADMINISTRATIVE SERVICES ONLY (ASO) PLAN CAN WORK FOR YOU AN INTRODUCTION FOR GROUPS OF 51-99 MT HOOD BlueCross BlueShield of Oregon ASO HOW AN ADMINISTRATIVE SERVICES ONLY (ASO) PLAN CAN WORK FOR YOU AN INTRODUCTION FOR GROUPS OF 51-99 Regence BlueCross BlueShield of Oregon is an Independent Licensee

More information

Inventory Management. Statement of Conflicts of Interest. Today s Goals 1/29/2014

Inventory Management. Statement of Conflicts of Interest. Today s Goals 1/29/2014 10 th Annual 340B Coalition Winter Conference Inventory Management Nicole N. Crase Director of Pharmacy Five Rivers Health Centers Pharmacy February 7, 2014 Statement of Conflicts of Interest Nicole Crase

More information

e -Prescribing An Information Brief

e -Prescribing An Information Brief e -Prescribing An Information Brief Prepared by: Maryland Health Care Commission June 2008 Introduction Technology creates efficiencies and opportunities in almost every industry, and health care is no

More information

Overview, Guidance & Training: Medicare Fraud, Waste & Abuse

Overview, Guidance & Training: Medicare Fraud, Waste & Abuse Overview, Guidance & Training: Medicare Fraud, Waste & Abuse Learning Objectives 1. To become familiar with the new educational component of fraud, waste and abuse (FWA) training regulations that govern

More information

DSH Litigation and 340B Program Update: What Participating Hospitals Need to Know and What They Should Be Doing

DSH Litigation and 340B Program Update: What Participating Hospitals Need to Know and What They Should Be Doing DSH Litigation and 340B Program Update: What Participating Hospitals Need to Know and What They Should Be Doing Presented by: Joe Metro, Partner Sal Rotella, Partner Agenda Disproportionate Share Hospital

More information

TEXAS MEDICAID: THE IMPACT OF MANAGED CARE ON MEDICAID RECIPIENTS INDEPENDENT PHARMACIES

TEXAS MEDICAID: THE IMPACT OF MANAGED CARE ON MEDICAID RECIPIENTS INDEPENDENT PHARMACIES TEXAS MEDICAID: THE IMPACT OF MANAGED CARE ON MEDICAID RECIPIENTS INDEPENDENT PHARMACIES A white paper evaluating the transition of the Prescription Drug Benefit into Medicaid Managed Care. Page 1 Executive

More information

Recommendations for Medicaid Pharmacy Reimbursement for the State of Louisiana

Recommendations for Medicaid Pharmacy Reimbursement for the State of Louisiana Recommendations for Medicaid Pharmacy Reimbursement for the State of Louisiana Prepared for the Louisiana Department of Health and Hospitals Baton Rouge, Louisiana June 2011 1 Table of Contents I. EXECUTIVE

More information

SUBCHAPTER G CONTRACT MANAGEMENT PART 842 CONTRACT ADMINISTRATION AND AUDIT SERVICES

SUBCHAPTER G CONTRACT MANAGEMENT PART 842 CONTRACT ADMINISTRATION AND AUDIT SERVICES SUBCHAPTER G CONTRACT MANAGEMENT PART 842 CONTRACT ADMINISTRATION AND AUDIT SERVICES Sec. 842.000 Scope of part. 842.070 Definitions. Subpart 842.1 Contract Audit Services 842.101 Contract audit responsibilities.

More information